Trazodone is an antidepressant that has become one of the most widely prescribed medications for insomnia in the United States. Originally approved by the FDA for major depressive disorder, trazodone's strong sedating properties at low doses have made it a go-to choice for psychiatrists treating adults with sleep difficulties — particularly when insomnia co-occurs with depression or anxiety.
Trazodone belongs to the serotonin antagonist and reuptake inhibitor (SARI) class. It works through a dual mechanism: blocking certain serotonin receptors (5-HT2A) while also inhibiting serotonin reuptake. This unique pharmacology gives it both antidepressant and sleep-promoting properties depending on the dose used.
At low doses (25 to 100 mg), trazodone's primary effect is blocking histamine H1 receptors and serotonin 5-HT2A receptors — both of which promote drowsiness and deeper sleep. At higher doses (150 to 400 mg), the serotonin reuptake inhibition becomes more prominent, producing antidepressant effects similar to SSRIs like Zoloft or Lexapro.
This dose-dependent pharmacology is why psychiatrists can use the same medication at different doses for different purposes — low-dose for sleep, higher-dose for depression, and sometimes combining both goals in a single treatment when a patient has both conditions.
Trazodone is one of the most commonly prescribed medications for insomnia in adults, despite this being an off-label use. Many psychiatrists prefer it over dedicated sleep medications like zolpidem (Ambien) because trazodone is not a controlled substance, has minimal abuse potential, does not produce tolerance with long-term use, and is safe for extended treatment periods.
For insomnia, trazodone is typically prescribed at 25 to 100 mg taken thirty minutes before bedtime. It helps with both falling asleep and staying asleep — addressing sleep-onset and sleep-maintenance insomnia. Unlike benzodiazepines, trazodone does not suppress deep sleep (slow-wave sleep), which is important for physical restoration and memory consolidation.
Trazodone is especially useful for insomnia that occurs alongside depression, PTSD, or anxiety. It can also counteract the insomnia side effect that some other antidepressants — particularly SSRIs and Wellbutrin — sometimes cause. Many psychiatrists prescribe low-dose trazodone as an adjunct to a morning SSRI specifically for this purpose.
The most common side effects include morning drowsiness (especially when first starting or at higher doses), dizziness, dry mouth, headache, and nausea. Taking trazodone with food can reduce nausea and may slightly delay the onset of sedation. Morning grogginess usually resolves within a few days as your body adjusts, or can be managed by taking the medication earlier in the evening or reducing the dose.
An uncommon but important side effect in men is priapism — a prolonged, painful erection unrelated to sexual arousal. While rare (estimated at 1 in 10,000 men), priapism is a medical emergency requiring immediate treatment. Men taking trazodone should be informed about this risk and seek emergency care if it occurs.
Orthostatic hypotension (a drop in blood pressure when standing up) can occur, especially in older adults or those taking blood pressure medications. Standing up slowly, particularly during the night, can help prevent falls associated with this effect.
For insomnia, most psychiatrists start at 25 to 50 mg at bedtime and adjust based on response. Some adults need 100 mg for adequate sleep, while others find 25 mg sufficient. For depression treatment, the starting dose is typically 150 mg per day (divided into doses), with gradual increases to 200 to 400 mg daily as tolerated.
Trazodone should be taken shortly before bedtime when used for sleep. It reaches peak blood levels in one to two hours and has a half-life of approximately five to nine hours — long enough to maintain sleep through the night for most adults without causing excessive next-day sedation.
While trazodone discontinuation syndrome is generally milder than with SSRIs, gradual tapering is still recommended — particularly at higher antidepressant doses. Stopping abruptly can cause rebound insomnia, anxiety, irritability, and flu-like symptoms. A typical taper reduces the dose by 50 mg every one to two weeks.
Both. Trazodone is FDA-approved as an antidepressant, but at the low doses of 25 to 100 mg that are most commonly prescribed today, it is used primarily as a non-habit-forming sleep aid. Higher doses of 150 to 400 mg produce its full antidepressant effect.
For sleep, trazodone works quickly — most adults feel its sedating effect within 30 to 60 minutes of taking a dose, which is why it is taken shortly before bedtime. Its antidepressant benefits, when used at higher doses, take two to four weeks to develop.
Yes, for many adults. Unlike benzodiazepines and Z-drugs such as Ambien, trazodone is not a controlled substance, does not typically cause tolerance or dependence, and is considered safe for extended nightly use under psychiatric supervision.
Trazodone is considered weight-neutral for most people and is far less likely to cause weight gain than many other antidepressants or sedating medications. Some adults notice a modest change in appetite, but significant weight gain is uncommon.
Trazodone has minimal abuse potential and is not habit-forming in the way sleep medications like benzodiazepines are. However, stopping it abruptly after regular use can cause rebound insomnia, so psychiatrists usually recommend tapering gradually.
Sleep problems and mental health conditions are deeply interconnected — treating one often requires addressing the other. At Elevate Psychiatry, our board-certified psychiatrists provide comprehensive evaluations and evidence-based medication management for adults dealing with insomnia, depression, anxiety, and related conditions. We serve patients across Miami and throughout Florida via telehealth.
Schedule an appointment to discuss trazodone or other treatment options for sleep and mental health.
For patients with bipolar depression or treatment-resistant insomnia, Seroquel (quetiapine) offers a different mechanism — acting on dopamine, serotonin, and histamine receptors to address both mood and sleep simultaneously.
Trazodone can be particularly helpful during the winter months when seasonal affective disorder disrupts sleep patterns — addressing both the insomnia and the depressive symptoms that accompany reduced daylight exposure.
Trazodone is commonly prescribed for insomnia. Learn more about evidence-based insomnia treatment options including CBT-I and medication approaches.
While medication can help with sleep, behavioral changes are equally important. Read about sleep hygiene habits that complement medical treatment for better sleep outcomes.
This content is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified psychiatrist before starting, changing, or stopping any medication.
